With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant
Model for end-stage liver disease-sodium and survival benefit in liver transplantation
β Scribed by Vitale, Alessandro; Bertacco, Alessandra; Gambato, Martina; D'Amico, Francesco; Morales, Rafael Ramirez; Frigo, Anna C.; Zanus, Giacomo; Burra, Patrizia; Angeli, Paolo; Cillo, Umberto
- Book ID
- 119880498
- Publisher
- Springer
- Year
- 2012
- Tongue
- English
- Weight
- 239 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We thank Garritsen et al. 1 for their interest in our article about differences in Model for End-Stage Liver Disease (MELD) and Model for End-Stage Liver Disease-Sodium (MELD-Na) scores determined at 3 different laboratories. 2 We agree that one of the important messages of our article is the import
The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr